is ozempic tirzepatide or semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Ozempic vs Mounjaro: Comparing GLP‑1

Increasing the frequency of blood glucose monitoring in the weeks following cessation to detect any deterioration in control early

For a full list of side effects, see the patient information leaflet

Tirzepatide (GLP-1/GIP Therapy) What It Does: Dual-action therapy (GLP-1 & GIP) for superior weight loss results Controls appetite & slows digestion Enhances insulin function & metabolism Helps lose significantly more weight than Semaglutide alone How It Works: Tirzepatide targets both GLP-1 & GIP receptors , boosting fat loss, energy balance, and metabolism

The steady-state factor: why weeks 4 through 5 are the real turning point This is where the pharmacology gets important

Patient C, 42, prioritized metabolic health and saw improved insulin resistance, reduced waist size, and sustained fat loss

Oral heparin: status review